The Future of Cancer Care in the United States-Overcoming Workforce Capacity Limitations

Lawrence N Shulman¹, Lisa Kennedy Sheldon^{2

3}, Edward J Benz^{4

5}

Affiliations

¹ Abramson Cancer Center, University of Pennsylvania, Philadelphia.
² Oncology Nursing Society, Pittsburgh, Pennsylvania.
³ The Cancer Center, St Joseph Hospital, Nashua, New Hampshire.
⁴ Dana-Farber Cancer Institute, Boston, Massachusetts.
⁵ Departments of Medical Oncology, Medicine, Pediatrics, and Genetics, Harvard Medical School, Boston, Massachusetts.

Lawrence N Shulman et al. JAMA Oncol. 2020.

. 2020 Mar 1;6(3):327-328.

doi: 10.1001/jamaoncol.2019.5358.

Lawrence N Shulman¹, Lisa Kennedy Sheldon^{2

3}, Edward J Benz^{4

5}

¹ Abramson Cancer Center, University of Pennsylvania, Philadelphia.
² Oncology Nursing Society, Pittsburgh, Pennsylvania.
³ The Cancer Center, St Joseph Hospital, Nashua, New Hampshire.
⁴ Dana-Farber Cancer Institute, Boston, Massachusetts.
⁵ Departments of Medical Oncology, Medicine, Pediatrics, and Genetics, Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment in

Value of Oncology Pharmacists in the Oncology Health Care Workforce-Reply.
Shulman LN, Sheldon LK, Benz EJ. Shulman LN, et al. JAMA Oncol. 2020 Jul 1;6(7):1121. doi: 10.1001/jamaoncol.2020.1291. JAMA Oncol. 2020. PMID: 32437527 No abstract available.
Value of Oncology Pharmacists in the Oncology Health Care Workforce.
Ignoffo RJ, Knapp K. Ignoffo RJ, et al. JAMA Oncol. 2020 Jul 1;6(7):1120-1121. doi: 10.1001/jamaoncol.2020.1288. JAMA Oncol. 2020. PMID: 32437553 No abstract available.